These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 20712522)

  • 1. Cancer pharmacogenomics: do cancer cell lines have the right stuff?
    Auman JT
    Pharmacogenomics; 2010 Aug; 11(8):1035-7. PubMed ID: 20712522
    [No Abstract]   [Full Text] [Related]  

  • 2. Transcriptional profiling in cancer: the path to clinical pharmacogenomics.
    Slonim DK
    Pharmacogenomics; 2001 May; 2(2):123-36. PubMed ID: 11368751
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacogenomics of a traditional Japanese herbal medicine (Kampo) for cancer therapy.
    Efferth T; Miyachi H; Bartsch H
    Cancer Genomics Proteomics; 2007; 4(2):81-91. PubMed ID: 17804870
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Perspectives and challenges of clinical pharmacogenomics in cancer.
    Pusztai L
    Pharmacogenomics; 2004 Jul; 5(5):451-4. PubMed ID: 15212580
    [No Abstract]   [Full Text] [Related]  

  • 5. Pharmacogenomics technique predicts chemotherapy success.
    Traynor K
    Am J Health Syst Pharm; 2006 Dec; 63(23):2304-6. PubMed ID: 17105999
    [No Abstract]   [Full Text] [Related]  

  • 6. Moving toward individualized cancer therapies.
    Tonon G; Anderson KC
    Clin Cancer Res; 2008 Aug; 14(15):4682-4. PubMed ID: 18676734
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cancer pharmacogenomics: DNA genotyping and gene expression profiling to identify molecular determinants of chemosensitivity.
    Auman JT; McLeod HL
    Drug Metab Rev; 2008; 40(2):303-15. PubMed ID: 18464047
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Pharmacogenetics and pharmacogenomics of cancers].
    Robert J
    Pathol Biol (Paris); 2004 Jul; 52(6):332-7. PubMed ID: 15261376
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cancer research. As questions grow, Duke halts trials, launches investigation.
    Couzin-Frankel J
    Science; 2010 Aug; 329(5992):614-5. PubMed ID: 20688986
    [No Abstract]   [Full Text] [Related]  

  • 10. Pharmacogenomics: from bedside to clinical practice.
    Marsh S; McLeod HL
    Hum Mol Genet; 2006 Apr; 15 Spec No 1():R89-93. PubMed ID: 16651374
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gene expression-driven diagnostics and pharmacogenomics in cancer.
    Wang Y
    Curr Opin Mol Ther; 2005 Jun; 7(3):246-50. PubMed ID: 15977422
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Personalized oncology: recent advances and future challenges.
    Kalia M
    Metabolism; 2013 Jan; 62 Suppl 1():S11-4. PubMed ID: 22999010
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Personalized medicine in oncology: where have we come from and where are we going?
    André F; Ciccolini J; Spano JP; Penault-Llorca F; Mounier N; Freyer G; Blay JY; Milano G
    Pharmacogenomics; 2013 Jun; 14(8):931-9. PubMed ID: 23746187
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Availability of pharmacogenetic and pharmacogenomic information in anticancer drug monographs in France: personalized cancer therapy.
    Albertini L; Siest G; Jeannesson E; Visvikis-Siest S
    Pharmacogenomics; 2011 May; 12(5):681-91. PubMed ID: 21619430
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacogenomics: current applications and future prospects towards personalized therapeutics.
    Vaiopoulou A; Gazouli M; Karikas GA
    J BUON; 2013; 18(3):570-8. PubMed ID: 24065466
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Translational approach for pharmacogenomics and personalized medicine].
    Zhang W; Zhou HH
    Yao Xue Xue Bao; 2011 Jan; 46(1):1-5. PubMed ID: 21465801
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Golden Helix Pharmacogenomics Days: educational activities on pharmacogenomics and personalized medicine.
    Squassina A; Severino G; Grech G; Fenech A; Borg J; Patrinos GP
    Pharmacogenomics; 2012 Apr; 13(5):525-8. PubMed ID: 22462744
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacogenomics for the primary care provider: why should we care?
    Teng K
    Cleve Clin J Med; 2011 Apr; 78(4):241-2. PubMed ID: 21460129
    [No Abstract]   [Full Text] [Related]  

  • 19. miRNA pharmacogenomics: the new frontier for personalized medicine in cancer?
    Dreussi E; Biason P; Toffoli G; Cecchin E
    Pharmacogenomics; 2012 Nov; 13(14):1635-50. PubMed ID: 23148639
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cancer drugs find a companion with new diagnostic tests.
    Schubert C
    Nat Med; 2011 Oct; 17(10):1157. PubMed ID: 21988963
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.